A retrospective observational study of a low fixed-dose rasburicase protocol for the treatment of tumor lysis syndrome in adults.
J Oncol Pharm Pract
; 28(6): 1326-1331, 2022 Sep.
Article
in En
| MEDLINE
| ID: mdl-34115548
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Tumor Lysis Syndrome
/
Hyperuricemia
Type of study:
Etiology_studies
/
Guideline
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Humans
Language:
En
Journal:
J Oncol Pharm Pract
Journal subject:
FARMACIA
Year:
2022
Document type:
Article
Affiliation country:
United States